Since the global pandemic in 2020, METHYL co has turned its focus to Taiwan’s ESG and public health needs. Together with our partners, we are committed to focusing on these needs through research, services, and practical solutions.
In entering the healthcare sector, our mission is helping to improve clinical experiences for patients and to offer quality medical devices.
PA3X, announced in 2025, is our proprietary medical device brand. Our vision is to deliver localized, high-performance vascular solutions for both patients and medical professionals. We are dedicated to designing simple, efficient, and safe workflows that could enhance the overall experience of caregivers and patients. We will continue to innovate and provide exceptional service, with the goal of becoming a reliable partner for medical professionals.